My Diabetes Information Blogs
New Drugs Await FDA approval.
06/13/06
Living Well, Clinical Trials, Treatment Options, Research, General
Its interesting that diseases create markets. Its ironic that a system that many argue has a relationship with greed actually produces many answers to the diabetes conundrum. Capitalism is not the perfect financing mechanism for diabetes and other diseases in health care. It does motivate people to find new answers and solutions.
In the diabetes world there is going to be a plain old competitive showdown. There are two drugs about to emerge for people with diabetes. Both are DPP-4 inhibitors – they help beta cells that make insulin. The drugs that are trying to gain the FDA’s favor are Norartis’s Galvus, and Januvia manufactured by Merck. Both show impressive results in helping people to control blood sugar.
To read more about Galvus and Januvia click on this article.